Alanyl-glutamine

DRUG6 trials

Conditions

Clostridia Difficile ColitisClostridioides Difficile InfectionClostridium Difficile DiarrheaClostridium Difficile InfectionDiarrheaDiarrhea, MalnutritionEnvironmental EnteropathyMalnutrition

Phase 2

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

TerminatedNCT02053350

University of VirginiaClostridium Difficile Infection

Start: 2015-04-30End: 2017-04-05Updated: 2022-06-07

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

RecruitingNCT04305769

University of VirginiaClostridia Difficile Colitis, Clostridioides Difficile Infection, Clostridium Difficile Diarrhea +1

Start: 2021-06-01End: 2027-06-30Target: 260Updated: 2024-10-26

Phase 3

HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition

WithdrawnNCT00133562

University of VirginiaDiarrhea, Malnutrition, Other Nutritional Deficiencies

Start: 2004-08-31End: 2006-05-31Target: 108Updated: 2008-10-28

Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition

WithdrawnNCT00338221

University of VirginiaDiarrhea, Malnutrition

Start: 2004-08-31End: 2005-04-30Target: 108Updated: 2008-10-28

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy

CompletedNCT01832636

Children's Hospital Medical Center, CincinnatiDiarrhea, Environmental Enteropathy, Malnutrition

Start: 2013-10-31End: 2015-12-31Updated: 2016-08-01

Unknown Phase

Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients

NCT05586646

Air Force Specialized Hospital, Cairo, EgyptPressure Ulcer

Start: 2022-04-01End: 2022-12-31Target: 200Updated: 2022-10-19

Related Papers

Alanyl-glutamine supplementation for<i>Clostridioides difficile</i>infection treatment (ACT): a double-blind randomised controlled trial study protocol